Analysis MiMedx Group, Inc. (MDXG)
5/31/2024
Analysis of MiMedx Group, Inc. (MDXG)
MiMedx Group, Inc. (MDXG) has been showing some fluctuations in its stock price recently. Looking at the technical indicators, we can see that the Relative Strength Index (RSI) has been hovering around the mid-range, indicating a neutral sentiment in the market. The Moving Average Convergence Divergence (MACD) indicator shows a slight decrease in momentum, with the MACD line crossing below the signal line.In terms of moving averages, the Simple Moving Average (SMA) and Exponential Moving Average (EMA) are both showing a downward trend, indicating a bearish sentiment. However, the Weighted Moving Average (WMA) is still slightly above the current price, suggesting a potential reversal.
Overall, based on the technical indicators, MiMedx Group, Inc. may be experiencing a period of consolidation or a potential reversal in the near future. Traders and investors should closely monitor the price action and key support/resistance levels to make informed decisions.
Earnings estimate
Based on the analysts' estimates for future quarterly and annual earnings per share (EPS), we can draw the following conclusions:1. For the current quarter ending on June 30, 2024, the average EPS estimate is $1.23, with a low estimate of $1.18 and a high estimate of $1.26. This shows an improvement compared to the EPS of $1.17 from the same quarter a year ago, as projected by 27 analysts.
2. Looking at the next quarter ending on September 30, 2024, analysts anticipate an average EPS of $1.42, ranging from a low estimate of $1.33 to a high estimate of $1.51. The year-ago EPS for this quarter was $1.35, according to 26 analysts.
3. For the current fiscal year ending on September 30, 2024, the average EPS estimate is $6.10, with a low estimate of $5.95 and a high estimate of $6.41. This reflects an increase from the previous year's EPS of $5.67, based on projections from 40 analysts.
4. Looking ahead to the next fiscal year ending on September 30, 2025, analysts forecast an average EPS of $6.69, with a low estimate of $5.92 and a high estimate of $7.31. The EPS for the previous fiscal year was $6.10, as estimated by 40 analysts.
Overall, the analysts' estimates suggest a generally positive outlook for the company's earnings per share, with expected growth in both the short term and the long term.
Revenue estimate
Based on the analysts' estimates for the future quarterly and annual sales of the company, we can draw the following conclusions:1. For the current quarter ending on June 30, 2024, the average sales estimate is $77,545,400,000, with a sales growth of 2% compared to the same quarter last year. The number of analysts providing estimates is 25. This indicates a moderate growth in sales for the current quarter.
2. For the next quarter ending on September 30, 2024, the average sales estimate is $85,501,800,000, with a sales growth of 3% compared to the same quarter last year. The number of analysts providing estimates is 25. This suggests a further increase in sales for the next quarter.
3. For the current fiscal year ending on September 30, 2024, the average sales estimate is $357,772,000,000, with a sales growth of 1% compared to the previous fiscal year. The number of analysts providing estimates is 38. This indicates a steady but modest growth in annual sales for the current fiscal year.
4. For the next fiscal year ending on September 30, 2025, the average sales estimate is $380,772,000,000, with a sales growth of 6% compared to the current fiscal year. The number of analysts providing estimates is 38. This suggests a more significant growth in sales for the next fiscal year.
Overall, the estimates point towards a positive trend of increasing sales for both the upcoming quarters and the next fiscal year, indicating potential growth and performance improvement for the company.
Growth estimates
Based on the consensus estimates provided, we can draw the following conclusions regarding the growth rate of the company for different periods:1. Current Quarter: The estimated growth rate for the current quarter is 5.6%.
2. Next Quarter: The estimated growth rate for the next quarter is 4.8%.
3. Current Year: The estimated growth rate for the current year is 7.5%.
4. Next Year: The estimated growth rate for the next year is 9.7%.
5. Past 5 Years (per annum): The average annual growth rate for the past 5 years is 20.1%.
6. Next 5 Years (per annum): The estimated average annual growth rate for the next 5 years is 11%.
These estimates suggest a positive growth trend for the company, with a slightly lower growth rate expected in the near term compared to the historical performance. However, the company is still projected to experience double-digit growth over the next 5 years according to analyst consensus.
Price target
Based on the analysts' forecast, the future price of the security is expected to range between $164 (low) and $250 (high), with a median estimate of $200 and an average estimate of $202.26. The current price of the security is $191.57.Earnings
The company's results for the most recent quarter, ending on April 30, 2025, have not been provided at this time. The previous quarter's results, ending on February 27, 2025, were handled by the Transfer Agent. The quarter before that, ending on January 31, 2025, had results released after hours. The results for the quarter ending on October 31, 2024, were not provided at the time. However, for the quarter ending on August 1, 2024, the company had an EPS estimate of 1.32.Main Statystic ðŸ§
The data provided includes financials, stock statistics, valuation metrics, stock price summary, and dividends and splits information for a specific company.In terms of financials, the company has strong operating cash flow and levered free cash flow, with a positive current ratio and a high total debt to equity ratio. The profit margin and operating margin are also healthy, indicating efficient operations. The company's fiscal year ends in September 2023, and it has shown a positive return on assets and return on equity.
Looking at stock statistics, the company has a low short ratio and a significant percentage of shares held by institutions. The stock price has a beta of 1.264 and has shown a slight increase over the fifty-two week period.
Valuation metrics show a relatively high PEG ratio and forward PE ratio, with the company being valued at a significant market capitalization. The price to book ratio and price to sales ratio are also on the higher side.
The stock price summary indicates the stock's performance over the past year, with details on moving averages and the fifty-two week range.
Lastly, the dividends and splits information includes details on dividend rates, payout ratios, dividend dates, and historical split information for the company.
Income statement 💸
These are the revenues. Here are the conclusions:1. The company's sales revenue has been increasing steadily over the past four fiscal years.
2. The gross profit margin seems to be consistent, indicating efficient cost management.
3. Net income has also shown a positive trend, reflecting the company's profitability.
4. Earnings per share (EPS) have been relatively stable over the years.
5. Operating income and EBITDA have generally increased, showing operational efficiency.
6. The company has been able to maintain a healthy EBIT margin.
7. Despite fluctuations in certain expenses and taxes, the overall financial performance appears strong and improving.
Balance Sheet
These are balance sheets. Here are the conclusions:1. The total assets have been increasing over the years, reaching $365,725,000,000 in 2018.
2. Current assets include cash, inventory, and receivables, with cash and cash equivalents showing fluctuations.
3. Non-current assets consist mainly of investments and advances, with a significant portion in machinery, furniture, and equipment.
4. Total liabilities have also been increasing, with the highest value of $302,083,000,000 in 2022.
5. Current liabilities include short-term debt, accounts payable, and other current liabilities.
6. Non-current liabilities comprise long-term debt and other non-current liabilities.
7. Shareholders' equity has shown variations, with the highest value of $90,488,000,000 in 2019.
8. Common stock and retained earnings are the major components of shareholders' equity.
9. The company seems to be investing heavily in non-current assets, which could be a strategy for long-term growth.
Cash Flow 💶
This is the cash flow statement. Here are some conclusions we can draw from the data:1. The company's free cash flow has been fluctuating over the years, with the highest value recorded in 2022 and the lowest in 2020.
2. Operating cash flow has generally been increasing year over year, indicating improved operational efficiency.
3. The company has been consistently paying interest and income taxes, with varying amounts each year.
4. The end cash position has also been fluctuating, reaching its highest value in 2020.
5. Financing activities show a pattern of common stock repurchase, issuance of long-term debt, and payment of dividends.
6. Investing activities include acquisitions, capital expenditures, and the sale/purchase of investments.
7. The company has been generating significant net income each year, with varying levels of depreciation and stock-based compensation.
8. Overall, the company's cash flow statement reflects a mix of operational, financing, and investing activities that impact its financial health and liquidity.
MACD of MDXG
This is not investment advice. Remember to verify the information provided here.
Get access to the full analysis
- Over 35 000 indexes
- CFD, Forex, Crypto and Stocks Exchange
- Over 150 Indicators
- Pattern and candle analysis
- Support and resistance levels
- Fundamental, technical and sentimental analysis
- Power from AI
